It was developed back in 2012, as a treatment for people with type 2 diabetes, but it took almost 5 years before it was FDA-approved for use
Great experience with Asymmetric Health
Ozempic (semaglutide) : approved for type 2 diabetes Wegovy (semaglutide) : approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with weight-related comorbidities Mounjaro (tirzepatide) : approved for type 2 diabetes Zepbound (tirzepatide) : approved for chronic weight management under the same criteria as Wegovy If you dont have diabetes, the weight-management brands (Wegovy, Zepbound) are what your doctor would prescribe, assuming you meet the criteria
Low-Glycemic Fruits: Berries, apples, and pears stabilize blood sugar
government will be expanding coverage of a popular new drug, making it more accessible to millions of Americans
It is no news that diabetes and obesity are serious health challenges that have gained global attention in recent years